Andrew DeVilbiss

Andrew DeVilbiss, Ph.D., is an Instructor in the Department of Internal Medicine at UT Southwestern Medical Center, affiliated with the Division of Hematology and Oncology. He joined the faculty in 2024 after completing a postdoctoral fellowship at the Children's Research Institute of UT Southwestern. His academic background includes dual bachelor's degrees in biochemistry and cellular/molecular biology from the University of Wisconsin, followed by a doctoral degree in philosophy from the same institution.

Dr. DeVilbiss' research focuses on hematopoiesis, stem cell biology, and metabolic regulation in blood cells. His work explores transcriptional mechanisms underlying erythropoiesis, metabolic pathways in somatic stem cells, and the role of redox signaling in immune and blood disorders. He has contributed to understanding how metabolic checkpoints and epigenetic modifications influence cell fate decisions in hematopoietic systems.

His publications highlight advancements in areas such as ascorbate deficiency effects on stem cell quiescence, KEAP1-mediated T cell adaptation, and autophagy's role in aging hematopoietic stem cells. Despite no explicitly listed scientific awards, his research has been published in high-impact journals like Blood, Science Immunology, and Cell Stem Cell.

Dr. DeVilbiss collaborates within interdisciplinary teams at UT Southwestern, focusing on translational research to bridge basic science and clinical applications in hematology and oncology. His current efforts emphasize metabolic regulation in somatic stem cells and the development of novel therapies targeting hematologic disorders.